← Open Payments lookup

RACHEL FILZER: Open Payments

NPI 1144588476 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,101 in 29 payments from 7 companies in 2025. Trend: 2023 $954 · 2024 $1,237 · 2025 $1,101

Food & beverage: $1,101
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$304
Otsuka America Pharmaceutical, Inc.13$234
Teva Pharmaceuticals USA, Inc.3$136
E.R. Squibb & Sons, L.L.C.1$122
ABBVIE INC.2$121
Lundbeck LLC2$96
Otsuka Pharmaceutical Development & Commercialization, Inc.2$88

Products named: CAPLYTA, REXULTI, ABILIFY MAINTENA, COBENFY, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across IA — which companies pay providers there.